Healthcare ❯Pharmaceuticals

Research and Development

Clinical Programs Oncology Treatments AI in Healthcare Innovation Healthcare Companies Investment Trends Gene Therapy Product Pipeline Market Dynamics Chronic Diseases

Sanofi’s $20 Billion US Investment Draws Criticism in France

Under pressure from Donald Trump’s tariff threats, Sanofi pledges significant US investments, sparking concerns over French industrial sovereignty.

Pharma CEOs Urge EU to Reform Pricing Policies as U.S. Investments Surge

Roche Announces $50 Billion U.S. Investment to Expand Manufacturing and R&D

Johnson & Johnson Launches $55 Billion U.S. Manufacturing and Research Expansion